Compare TTC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTC | ICLR |
|---|---|---|
| Founded | 1914 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Tools/Hardware | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.3B |
| IPO Year | 1994 | 2001 |
| Metric | TTC | ICLR |
|---|---|---|
| Price | $91.63 | $143.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $104.00 | ★ $178.62 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 06-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.18 | N/A |
| Revenue | ★ $2,618,650,000.00 | N/A |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $4.45 | N/A |
| P/E Ratio | $42.29 | ★ $12.91 |
| Revenue Growth | ★ 4.53 | N/A |
| 52 Week Low | $67.64 | $66.57 |
| 52 Week High | $105.19 | $211.00 |
| Indicator | TTC | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 56.72 |
| Support Level | $85.60 | $99.11 |
| Resistance Level | $96.15 | $193.87 |
| Average True Range (ATR) | 3.08 | 6.89 |
| MACD | 0.33 | -1.32 |
| Stochastic Oscillator | 65.99 | 37.33 |
The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.